虎杖苷作用機(jī)制 - Medchemexpress - MCE中國(guó)_第1頁(yè)
虎杖苷作用機(jī)制 - Medchemexpress - MCE中國(guó)_第2頁(yè)
虎杖苷作用機(jī)制 - Medchemexpress - MCE中國(guó)_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Product Data SheetPolydatinCat. No.: HY-N0120ACAS No.: 27208-80-6分式: CHO分量: 390.38作靶點(diǎn): Autophagy; Apoptosis; Mitophagy作通路: Autophagy; Apoptosis儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 29 mg/mL (74.29 mM)* means soluble, but saturation unknown.SolventMass

2、1 mg 5 mg 10 mgConcentration制備儲(chǔ)備液1 mM 2.5616 mL 12.8080 mL 25.6161 mL5 mM 0.5123 mL 2.5616 mL 5.1232 mL10 mM 0.2562 mL 1.2808 mL 2.5616 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液的保存式和期限:-80C, 6 months; -20C, 1 month。-80C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)內(nèi)使,-20C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)內(nèi)使。體內(nèi)實(shí)驗(yàn)請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍?。以下溶解?/p>

3、都請(qǐng)先按照 In Vitro 式配制澄清的儲(chǔ)備液,再依次添加助溶劑:為保證實(shí)驗(yàn)結(jié)果的可靠性,澄 的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使; 以下溶劑前顯的百分 指該溶劑在您配制終溶液中的體積占;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的式助溶1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.40 mM); Clear solution此案可獲得 2.5 mg/mL (6.40 mM,飽和度未知) 的澄清溶液。以 1 mL 作液為例,取

4、100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 400 L PEG300 中,混合均勻;向上述體系中加50 L Tween-80,混合均勻;然后繼續(xù)加 450 L 理鹽定容 1 mL。2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (6.40 mM); Clear solutionPage 1 of 2 www.MedChemE此案可獲得 2.5 mg/mL (6.40 mM,飽和度未知) 的澄清溶液。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加

5、到 900 L 20% 的 SBE-CD 理鹽溶液中,混合均勻。3. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (6.40 mM); Clear solution此案可獲得 2.5 mg/mL (6.40 mM,飽和度未知) 的澄 溶液,此案不適于實(shí)驗(yàn)周 期在半個(gè)以上的實(shí)驗(yàn)。以 1 mL 作液為例,取 100 L 25.0 mg/mL 的澄 DMSO 儲(chǔ)備液加到 900 L 油中,混合均勻。BIOLOGICAL ACTIVITY物活性 Polydatin提取從傳統(tǒng)中藥虎杖根,在多個(gè)實(shí)驗(yàn)?zāi)P椭芯哂锌寡鬃鳌olydatin (Pi

6、ceid) 可抑制G6PD,并誘導(dǎo)氧化和內(nèi)質(zhì)應(yīng)激IC & Target NF-B, Autophagy體外研究 Polydatin protects cerebral cells from ischemic damages via improvement of microcirculation and inhibition ofplatelet aggregation. In addition, polydatin inhibits ICAM-1 expression in endothelial cells stimulated bylipopolysaccharide; it also a

7、ttenuates adhesion between white blood cells and endothelial cells1.Polydatin inhibits cancer cell proliferation and cell cycle progression4.Polydatin induces ER stress-driven cell death4.體內(nèi)研究 Polydatin could significantly increase the activity of SOD and the heart rate, attenuate myocardial patholo

8、gicaldamage, decrease MDA content, slightly increase arterial pressure and GSH-Px activity, reduce intervals of QRS, QT and ST, and lower FFA content2.PROTOCOLCell Assay 3 The effect of polydatin on mMEC viability is evaluated with an MTT assay. mMECs are incubated in the presence orabsence of vario

9、us concentrations of polydatin (25, 50 and 100 g/mL) and DEX (100 g/mL) for 24 h. Next, 20 L ofMTT (5 mg/mL) is added to each well and incubated for 4 h. After the supernatants are removed and the formazan isdissolved with 150 L of DMSO in each well, the optical density (OD) value is measured at 570

10、 nm on a microplatereader3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Rats: Rats are divided into six groups by random assignment and treated as follows: in normal group and polydatinAdministration 23 control group: rats are administrated wi

11、th CMC-Na and polydatin (200 mol/kg) by gavage respectively, and givennormal saline (NS) by tail intravenous (iv) injection with the same volume; in DOX group: rats are injected with DOXby cauda vein for 4 weeks (3 mg/kg per week), the cumulative dosage is 12 mg/kg similar to that in the research of

12、Chang et al2.Mice: Polydatin is dissolved in dimethyl sulfoxide (DMSO) and diluted in Dulbeccos modified Eagles medium(DMEM). Sixty adult female postpartum and lactating BALB/c mice (68 weeks old, weighing 3540 g) are obtained.Control group (CG): The mice are treated with 100 L of PBS as a vehicle c

13、ontrol. Polydatin groups: 24h after S aureusinfection, the mouse model of S aureus mastitis is intraperitoneally administered polydatin at 15, 30 and 45 mg/kg3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Page 2 of 3 www.MedChemEREFERENCES1. Cheng Y,

14、 et al. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusioninjury. Brain Res. 2006 Sep19;1110(1):193-200.2. Wang HL, et al. Synergistic effects of Polydatin and Vitamin C in Inhibiting Cardiotoxicity induced by Doxorubicin in rats. Fundam Clin Ph

15、armacol. 2016Nov 28. Epub ahead of print3. Jiang KF, et al. Polydatin ameliorates Staphylococcus aureus-induced mastitis in mice via inhibiting TLR2-mediated activation of the p38 MAPK/NF-Bpathway. Acta Pharmacol Sin. 2016 Nov 28. Epub ahead of print4. Luigi Mele, et al. A New Inhibitor of glucose-6-phosphate Dehydrogenase Blocks Pentose Phosphate Pathway and Suppresses Malignant Proliferationand Metastasis in Vivo. Cell Death Dis. 2018 May

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論